PFIS Stock News 47.20 05/13/2014 15:28:51 Peoples Finl Svcs Co

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Peoples Finl Svcs Co (PFIS) 47.20 $PFIS

Peoples Financial Services announces 35% higher dividend of USD0.31 per share over last year
M2 - Mon Apr 28, 3:03AM CDT
The board of directors of Peoples Financial Services Corp (NASDAQ OMXFIS), the parent company of Peoples Security Bank and Trust Company, authorised a dividend of USD0.31 per share for the quarter, the company reported on Friday.

PEOPLES FINANCIAL SERVICES CORP. Reports First Quarter 2014 Earnings
PR Newswire - Fri Apr 25, 12:45PM CDT
Peoples Financial Services Corp. ("Peoples" (NASDAQ OMX: PFIS), the bank holding company for Peoples Security Bank and Trust Company, today reported unaudited financial results at and for the three months ended March 31, 2014. Peoples, which completed a merger with Penseco Financial Services Corporation ("Penseco" on November 30, 2013, reported net income of $4.7 million, or $0.62 per basic and diluted weighted average share for the quarter ended March 31, 2014, compared to $2.5 million, or $0.56 per share, for the comparable quarter of 2013. Earnings per share amounts in prior periods are based on restated shares outstanding. The merger between Peoples and Penseco was accounted for as a reverse acquisition of Peoples by Penseco. As a result of the reverse merger, Peoples is the legal acquirer and Penseco is the accounting acquirer. In a reverse merger the historical financial statements are those of the accounting acquirer. The results for the quarter ended March 31, 2014, include pre-tax merger related expenses of approximately $608.0 thousand. The conversion of the core processing system is scheduled to be completed at the end of April, 2014. Accordingly, cost savings associated with such action are not anticipated to be realized until sometime beginning in the third quarter of 2014.

PEOPLES FINANCIAL SERVICES CORP. Declares Cash Dividend
PR Newswire - Fri Apr 25, 12:09PM CDT
The Board of Directors of Peoples Financial Services Corp. (NASDAQ OMX: PFIS) today declared a quarterly dividend of $0.31 per share. The dividend, which is a 35% increase over the comparable quarter last year, is payable June 13, 2014, to shareholders of record May 30, 2014.

Insiders Were Right: PFIS Makes New 52-Week High
MarketNewsVideo.com - Fri Apr 04, 12:35PM CDT
In trading on Friday, shares of Peoples Financial Services Corp touched a new 52-week high of $43.00/share. That's a 29.87% rise, or $9.89 per share from the 52-week low of $33.11 set back on 04/15/2013.

Peoples Financial Services Corp. Announces NASDAQ Listing
PR Newswire - Mon Mar 31, 1:37PM CDT
Peoples Financial Services Corp. (OTCQB: PFIS), the bank holding company of Peoples Security Bank and Trust Company, today announced that it has satisfied the initial listing criteria of The Nasdaq Stock Market, LLC, and its common stock is expected to begin trading on the NASDAQ Global Select Market® on April 2, 2014, under the ticker symbol "PFIS."

Peoples Financial Services Corp. Announces Common Stock Repurchase Plan
PR Newswire - Wed Feb 12, 3:47PM CST
Peoples Financial Services Corp. (OTCQB: PFIS) ("Peoples", the bank holding company of Peoples Security Bank and Trust Company, announced today that its Board of Directors has authorized a stock repurchase plan providing for the purchase of up to 370,000 shares of its outstanding common stock. The timing, price and volume of repurchases will be based on market conditions, relevant securities laws and other factors. The stock repurchases may be made from time to time on the open market or in privately negotiated transactions. The stock repurchase program does not require Peoples to repurchase any specific number of shares, and Peoples may terminate the repurchase program at any time. After giving effect to its recent merger with Penseco Financial Services Corporation, Peoples currently has approximately 7,552,944 shares of common stock outstanding.

Peoples Financial Services Corp. Reports Earnings
PR Newswire - Wed Feb 12, 3:46PM CST
Peoples Financial Services Corp. ("Peoples" (OTCQB: PFIS), the bank holding company for Peoples Security Bank and Trust Company, today reported unaudited financial results at and for the three and twelve-month periods ended December 31, 2013. Peoples, which completed a merger with Penseco Financial Services Corporation ("Penseco" on November 30, 2013, reported net income of $5.1 million, or $1.07 per basic and diluted weighted average share, compared to $10.6 million, or $2.37 per share, reported by Penseco for the twelve months ended December 31, 2012. Peoples reported a net loss of $2.8 million, $0.50 per share, for the three months ended December 31, 2013, compared to net income of $2.7 million, or $0.61 per share, reported by Penseco for the three months ended December 31, 2012.

Peoples Financial Services Corp. Completes Merger with Penseco Financial Services Corporation
Business Wire - Mon Dec 02, 12:17PM CST
Craig W. Best, President and CEO of Peoples Financial Services Corp. ("Peoples"; OTCQB: PFIS) announced today the closing of its merger with Penseco Financial Services Corporation on November 30, 2013. Peoples also announced the merger of its subsidiary bank, Peoples Neighborhood Bank with Penn Security Bank and Trust Company on December 1, 2013. The combined bank will operate as Peoples Security Bank and Trust Company. Full integration of the banks is expected to be completed in April, 2014.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 342

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 44

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 13

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading